Order Article Reprints

Sasaki R, Nagata K, Fukushima M, Haraguchi M, Miuma S, Miyaaki H, Soyama A, Hidaka M, Eguchi S, Shigeno M, et al. Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma. Cancers. 2022; 14(3):827. https://doi.org/10.3390/cancers14030827

Sasaki, Ryu, Kazuyoshi Nagata, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Akihiko Soyama, Masaaki Hidaka, Susumu Eguchi, Masaya Shigeno, and et al. 2022. "Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma" Cancers 14, no. 3: 827. https://doi.org/10.3390/cancers14030827

Sasaki, R., Nagata, K., Fukushima, M., Haraguchi, M., Miuma, S., Miyaaki, H., Soyama, A., Hidaka, M., Eguchi, S., Shigeno, M., Yamashima, M., Yamamichi, S., Ichikawa, T., Kugiyama, Y., Yatsuhashi, H., & Nakao, K. (2022). Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma. Cancers, 14(3), 827. https://doi.org/10.3390/cancers14030827